
Open access
Author
Date
2014Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-010409531Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETH-ZürichSubject
ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); ANTIKÖRPERTECHNIKEN (IMMUNOLOGISCHE TECHNIKEN); IMMUNKOMPLEX + ANTIGEN-ANTIKÖRPER KOMPLEX (IMMUNOLOGIE); FIBRONEKTIN (GLYKOPROTEINE); KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); TARGETED DRUGS (PHARMACOLOGY); MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); ANTIBODY TECHNIQUES (IMMUNOLOGICAL TECHNIQUES); IMMUNE COMPLEX + ANTIGEN-ANTIBODY COMPLEX (IMMUNOLOGY); FIBRONECTIN (GLYCOPROTEINS); CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY)Organisational unit
02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
Notes
Diss., Eidgenössische Technische Hochschule ETH Zürich, Nr. 22076.More
Show all metadata
ETH Bibliography
yes
Altmetrics